With that in mind, let's consider two stocks that people in their 30s -- who are still a good distance away from retirement - ...

The move would add another barrier for parents who want to vaccinate healthy children ahead of the respiratory virus season.

Moderna ( ($MRNA) ) has risen by 10.01%. Read on to learn why. Moderna’s stock has experienced a notable increase of 10.01% over the past week, ...

The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...

The average short interest in the S&P 500 Health Care Index Sector (XLV) dipped slightly in July to 1.95% from 1.96% in June.

The U.S. Food and Drug Administration may not renew its authorization for Pfizer's COVID-19 vaccine approved for children ...

Enphase Energy (ENPH) retained its spot as the most shorted S&P 500 (SP500) stock as a percentage of float in July, followed ...

Organizations are slowly merging HR and IT departments to create a unified approach to the workforce and the technology that ...

Shares of the biotech Moderna were up on Wednesday, as the Trump administration’s shifting position on messenger RNA-based ...

The Food and Drug Administration (FDA) is considering revoking the authorization of Pfizer’s COVID-19 vaccine for healthy ...

Parents in the United States who want to vaccinate their young children against Covid-19 this fall may face a growing set of ...

Cold Chain told the state through a Worker Adjustment and Retraining Notification that 82 jobs will be cut in Franklin.